首页 | 本学科首页   官方微博 | 高级检索  
检索        


Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Complex Coronary Artery Disease
Institution:1. Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada;2. Rangueil University Hospital, Toulouse, France;3. Hospital Universitario Virgen de la Victoria, Malaga, Spain;4. Cardiovascular Institute, Hospital Clinico San Carlos, IdISSC, Madrid, Spain;5. Reims University Hospital, Reims, France;6. Hospital Marques de Valdecilla, Santander, Spain;7. Hospital Universitari Vall d’Hebron, Barcelona, Spain;8. Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France;9. Hospital Universitario Central de Asturias, Oviedo, Spain;10. Hospital Santa Creu i Sant Pau, Barcelona, Spain;11. Hospital Gregorio Maranon, Madrid, Spain;12. Hospital Clinic de Barcelona, Barcelona, Spain;13. Hospital Germans Trias i Pujol, Badalona, Spain;14. Instituto do Coração (InCor), Heart Institute, University of Sao Paulo, Sao Paulo, Brazil
Abstract:ObjectivesThe aim of this study was to compare, in a cohort of patients with complex coronary artery disease (CAD) and severe aortic stenosis (AS), the clinical outcomes associated with transfemoral transcatheter aortic valve replacement (TAVR) (plus percutaneous coronary intervention PCI]) versus surgical aortic valve replacement (SAVR) (plus coronary artery bypass grafting CABG]).BackgroundPatients with complex CAD were excluded from the main randomized trials comparing TAVR with SAVR, and no data exist comparing TAVR + PCI vs SAVR + CABG in such patients.MethodsA multicenter study was conducted including consecutive patients with severe AS and complex CAD (SYNTAX Synergy Between PCI with Taxus and Cardiac Surgery] score >22 or unprotected left main disease). A 1:1 propensity-matched analysis was performed to account for unbalanced covariates. The rates of major adverse cardiac and cerebrovascular events (MACCE), including all-cause mortality, nonprocedural myocardial infarction, need for new coronary revascularization, and stroke, were evaluated.ResultsA total of 800 patients (598 undergoing SAVR + CABG and 202 undergoing transfemoral TAVR + PCI) were included, and after propensity matching, a total of 156 pairs of patients were generated. After a median follow-up period of 3 years (interquartile range: 1-6 years), there were no significant differences between groups for MACCE (HR for transfemoral TAVR vs SAVR: 1.33; 95% CI: 0.89-1.98), all-cause mortality (HR: 1.25; 95% CI: 0.81-1.94), myocardial infarction (HR: 1.16; 95% CI: 0.41-3.27), and stroke (HR: 0.42; 95% CI: 0.13-1.32), but there was a higher rate of new coronary revascularization in the TAVR + PCI group (HR: 5.38; 95% CI: 1.73-16.7).ConclusionsIn patients with severe AS and complex CAD, TAVR + PCI and SAVR + CABG were associated with similar rates of MACCE after a median follow-up period of 3 years, but TAVR + PCI recipients exhibited a higher risk for repeat coronary revascularization. Future trials are warranted.
Keywords:aortic stenosis  coronary artery disease  surgical aortic valve replacement  transcatheter aortic valve replacement  AS"}  {"#name":"keyword"  "$":{"id":"kwrd0035"}  "$$":[{"#name":"text"  "_":"aortic stenosis  CABG"}  {"#name":"keyword"  "$":{"id":"kwrd0045"}  "$$":[{"#name":"text"  "_":"coronary artery bypass grafting  CAD"}  {"#name":"keyword"  "$":{"id":"kwrd0055"}  "$$":[{"#name":"text"  "_":"coronary artery disease  MACCE"}  {"#name":"keyword"  "$":{"id":"kwrd0085"}  "$$":[{"#name":"text"  "_":"major adverse cardiac and cerebrovascular event(s)  PCI"}  {"#name":"keyword"  "$":{"id":"kwrd0095"}  "$$":[{"#name":"text"  "_":"percutaneous coronary intervention  PS"}  {"#name":"keyword"  "$":{"id":"kwrd0105"}  "$$":[{"#name":"text"  "_":"propensity score  SAVR"}  {"#name":"keyword"  "$":{"id":"kwrd0115"}  "$$":[{"#name":"text"  "_":"surgical aortic valve replacement  STS"}  {"#name":"keyword"  "$":{"id":"kwrd0125"}  "$$":[{"#name":"text"  "_":"Society of Thoracic Surgeons  TAVR"}  {"#name":"keyword"  "$":{"id":"kwrd0135"}  "$$":[{"#name":"text"  "_":"transcatheter aortic valve replacement
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号